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Abstract
Background: Influenza infections can lead to viral pneumonia, upper respiratory tract infection or facilitate co-infection
by other pathogens. Influenza is associated with the exacerbation of chronic conditions like diabetes and cardiovascular
disease and consequently, these result in acute hospitalizations. This study estimated the number, proportions and
costs from a payer perspective of hospital admissions related to severe acute respiratory infections.
Methods: We analyzed retrospectively, a database of all acute inpatient stays from a non-random sample of eleven
hospitals using the Belgian Minimal Hospital Summary Data. Codes from the International Classification of Diseases,
Ninth Revision, Clinical Modification was used to identify and diagnose cases of pneumonia and influenza (PI), respiratory
and circulatory (RC), and the related complications.
Results: During 2002–2007, we estimated relative hospital admission rates of 1.69% (20960/1237517) and 21.79%
(269634/1237517) due to primary PI and RC, respectively. The highest numbers of hospital admissions with primary
diagnosis as PI were reported for the elderly patient group (n = 10184) followed by for children below five years of age
(n = 3451).
Of the total primary PI and RC hospital admissions, 56.14% (11768/20960) and 63.48% (171172/269634) of cases had at
least one possible influenza-related complication with the highest incidence of complications reported for the elderly
patient group. Overall mortality rate in patients with PI and RC were 9.25% (1938/20960) and 5.51% (14859/269634),
respectively. Average lengths of hospital stay for PI was 11.6 ± 12.3 days whereas for RC it was 9.1 ± 12.7 days. Annual
average costs were 20.2 and 274.6 million Euros for PI and RC hospitalizations. Average cost per hospitalization for PI
and RC were 5779 and 6111 Euros (2007), respectively. These costs increased with the presence of complications
(PI: 7159, RC: 7549 Euros).
Conclusion: The clinical and economic burden of primary influenza hospitalizations in Belgium is substantial. The
elderly patient group together with children aged <18 years were attributed with the majority of all primary PI
and RC hospitalizations.
Trial registration: Not applicable.
Keywords: Hospital admission, Influenza, Pneumonia, Costs, Complication
* Correspondence: rcrott@hotmail.co.uk
1Research Institute of Health and Society (IRSS), Catholic University of
Louvain, Clos Chapelle aux Champs 30 bte 3013, Brussels 1200, Belgium
Full list of author information is available at the end of the article
ARCHIVES OF PUBLIC HEALTH
© 2014 Crott et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Crott et al. Archives of Public Health 2014, 72:33
http://www.archpublichealth.com/content/72/1/33
Background
Influenza, caused by a contagious respiratory virus, is a
common upper respiratory tract illness that results in
substantial morbidity and mortality worldwide. Add-
itionally, influenza results in high health care costs and
places significant clinical and economic burden on the
patient and society [1]. Uncomplicated influenza is char-
acterized by non-specific respiratory symptoms among
other general conditions (fever, myalgia, headache, non-
productive cough, sore throat and rhinitis) which generally
resolve after 3 − 7 days. It is well-known that influenza dir-
ectly causes viral pneumonia, secondary bacterial pneu-
monia, upper respiratory tract infections such as sinusitis
and otitis media; or facilitates co-infection with other viral
and bacterial respiratory pathogens [1,2]. Infection with
influenza virus is also associated with the exacerbation of
underlying chronic conditions like diabetes, pulmonary
(asthma and chronic obstructive pulmonary disorder) and
cardiovascular diseases. Evidence suggests that influenza-
related complications occur more frequently and are more
severe in groups that are at a higher risk of respiratory dis-
ease, metabolic disorders and cardiovascular diseases,
resulting in high resource utilization and mortality rates.
Besides common complications related to influenza,
young children are also susceptible to additional non-
respiratory tract complications. In some circumstances,
infected individuals do not show any symptoms and remain
subclinical [1]. Although relatively rare, hospitalization for
both respiratory tract and non-respiratory influenza-
associated complications could be expensive. There is
increasing evidence that influenza infection is not only
associated with severe acute respiratory infection such
as pneumonia but that it also exacerbates in a number
of cases with preexisting chronic diseases, notably car-
diovascular ones [3-5]. Influenza-associated complica-
tion rates are however influenced by a variety of factors
and are notoriously prone to underreporting [6-8].
In Belgium as in most other developed countries the
burden of disease and impact on health care systems can
be divided into several components which can be pre-
sented as a pyramid. At the base of the pyramid are
asymptomatic individuals who do not seek health care.
Moving bottom-up are individuals with symptomatic un-
complicated cases of influenza who are likely to stay a
few days out of work or school since they are unable to
perform their daily activities. However, a small propor-
tion of these individuals seek medical ambulatory care,
generally through a general practitioner (GP) who in
some instances may order a laboratory confirmation test.
It is widely established that with the development of
influenza-related complications subsequent to infection
with the virus, detection of the virus is not usually pos-
sible due to its action in indirectly triggering or facilitat-
ing other diseases. Moreover, there is no satisfying rapid
point-of-care test with high accuracy available for detec-
tion of influenza. Consequently, it becomes difficult to
estimate the burden of disease of influenza. For compli-
cated cases, when pneumonia is present or suspected, the
GP may either refer the patient to a hospital or the patient
may visit a hospital emergency department where the pa-
tient may be hospitalized for further treatment. Patients
and GP’s are free to choose the hospital of their choice in
the whole country as there is no restriction in the regional
access of care in Belgium.
Accurate estimates of the burden of diseases associ-
ated with influenza are therefore important in designing
prevention and control measures in both healthy indi-
viduals and at-risk groups. We report here findings from
a retrospective analysis of data on pneumonia and influ-
enza (PI) and respiratory and circulatory (RC) hospital
admissions from the payer’s perspective in Belgium for
the time period of 2002–2007. The precise estimate of
the attributable fraction of influenza hospitalization is
outside the scope of this study.
Methods
Data sources
The School of Public Health of the University of Louvain
routinely collects data on classical inpatient stays from
hospitals that participate voluntarily each year. The hos-
pitals included in the analysis constitute a non-random
convenience sample and are distributed across different
regions of Belgium (Brussels [n = 2], Flanders [n = 1]
Wallonia [n = 8]). Of these eleven hospitals, three are
academic hospitals and the remaining hospitals are non-
academic.
Data on inpatient stays are based on the official Belgian
Minimum Hospital Summary Data (BMHSD) definition
of hospital discharge. Hospital stay of each patient is de-
scribed in the BMHSD set (called “RCM” until 2007)
which is recorded for the whole stay after the patient has
been discharged. These discharge records are sent to
the Ministry of Health twice each year (i.e. June and
December). Discharge records for inpatient stays (i.e.
when the patient has spent at least one night at the
hospital) documenting year of discharge between 2002
and 2007 were included in the study. Therefore, hospital
records of patients admitted through the emergency de-
partments and who were discharged within 24 hours from
that department were not included in the present analysis.
Hospital discharge diagnoses
Definition of primary main diagnosis
For each patient stay, the BMHSD set contains data on
the primary diagnosis and several secondary diagnoses
coded as per the International Classification of Diseases,
Ninth Revision, Clinical Modification (ICD9_CM) codes.
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The primary diagnosis was defined as the main reason
for hospitalization of the patient for the total duration of
hospital stay. Primary diagnosis codes were as follows: PI -
ICD9_CM codes 480 − 487 included, and RC - 460 − 519
and 390 − 459.
In the database there are up to maximum 29 different
secondary ICD9 codes recorded for each stay. The ICD9-
CM codes classification version used by the Belgian hospi-
tals did not vary during the period under study.
Definition of other diagnoses and influenza-related
complications
The secondary diagnoses describe complications of pri-
mary diagnosis and other concomitant pathologies that
may have been present or needed to be cared for dur-
ing the hospital stay (Table 1) [9-15]. A list of compli-
cations for all patients was used to diagnose possible
influenza-related complications among the secondary
diagnoses fields of each hospital admission record, irre-
spective of the age group for all patients. For children,
an additional list of child-specific potential complica-
tions was created that was combined with the above
“all patients” list and corrected for overlapping ICD9
codes (Tables 1 and 2).
Costs associated with influenza-related hospital
admissions
The cost per hospital admission was based on the hos-
pital discharge records from inpatient stays with 2007 as
the discharge year. For each hospitalization, the hospi-
tals send a detailed invoice based on the national
reimbursement list including medical procedures to
the patient’s insurer. Therefore, the costs considered
in this study are reimbursement costs. Records for
only those patients who are covered by the Belgian
National Health insurance (approx. 98% Belgian popu-
lation) were available in the database and were there-
fore considered in the cost analyses. The cost per
hospital admission included five components – hospital
stay charges, pharmacy, laboratory, intensive care and
medical procedures and others.
Statistical analyses
The hospital discharge data was aggregated by month
based on the month of admission. Absolute numbers
and rates of hospital admissions were estimated by pri-
mary diagnosis type (PI and RC), complications and age
groups. Five patient groups considered in the present
analysis were – infants and toddlers (below 5 years of
age), children and adolescents (ages 5 − 17 years), young
adults (ages 18 − 49 years), mature adults (ages 50 −
64 years) and the elderly (ages 65 years and above). For
mortality data and referrals from nursing home in the
elderly the proportion of cases was also estimated. Average
length of hospital stay, average annual costs and average
costs per hospital admission (Euros) by primary diagnosis
type, complications and age groups were also estimated. All
data preparation and analysis were performed using SAS/
STAT® v9.2 or Microsoft Excel® software.
Results
Hospital admissions by primary discharge diagnosis and
complications
The total number of hospital admissions due to any cause
in the eleven hospitals observed from the years 2002–2007
was 1237517; of these, 1.69% (20960/1237517) and 21.79%
(269634/1237517) were classified as primary PI and
RC, respectively (PI = 3493 per year (range 3209-3859)
RC = 44939 per year (range: 44470-45102). The high-
est rate of PI and RC hospitalizations were reported in
the elderly patient group followed by children below
five years of age (Table 3/Figure 1). The burden of
hospitalization due to PI and RC was the greatest in the
elderly patient group followed by in children aged <18 years.
(Table 3/Figure 1). Annual numbers of primary PI and RC
hospital admissions (including with and without complica-
tions) were similar over the years (data not shown). Of the
total primary PI and RC hospital admissions, 56.14%
(11,768/20,960) and 63.48% (171172/269634) had at least
one influenza-related complication. Complications were
most frequently observed in the elderly patient group for
both the primary groups, PI and RC (Table 3).
The overall mortality rate in patients with primary
diagnosis PI and RC were 9.25% (1938/20960) and 5.51%
Table 1 Code Definition of influenza-related
complications for all patients
Influenza-related complications
for all patients
ICD-9 codes
Asthma 493, V17.5
Cardiovascular disease 989.1, 402.01, 402.11, 402.91, 404.01,
404.03, 404.11, 404.13, 404.91, 404.93,
428, 413, 412, 410, 411, 414
Chronic obstructive pulmonary
disorder
490, 491, 492, 496
Diabetes 250.xx, 249.xx, V18.0, V77.1, 253.5, 588.1
Hypertension 401-405, 997.91, 459.3x (except codes
of the 402 and 404 chapters, already
listed under cardiovascular disease)
Pneumococcal pneumonia 481
Secondary respiratory infection 480, 482, 483, 484, 485, 486, 460, 462,
466, 390, 391, 392, 041, 465.9, 034.0,
038.0, 320.2, 482.31
Stroke 430-438, 342
Source: International Classification of Disease – 9th Edition; Codes were
selected after a review of the literature [9-15].
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(14859/269634), respectively. Among PI and RC hospital
admissions that resulted in death, 4.07% (PI) and 32.16%
(RC) had at least one related-complication. The mortality
rate was approximately two-fold in patients with compli-
cations for primary PI hospital admissions compared to
those who developed complications in primary RC hos-
pital admissions (12.12% [1426/11768] versus 6.59%
[11279/171172]).
Length of hospital stay by primary discharge diagnosis
and Complications
The average length of hospital stay in patients with pri-
mary diagnosis of PI and RC were 11.6 ± 12.3 days and
9.1 ± 12.7 days, respectively. The average length of hos-
pital stay in patients with influenza-related complica-
tions was observed to be higher than in the patients
without complications for primary PI hospital admis-
sions (14.6 days vs. 7.8 days) and primary RC hospital
admissions (11.3 days vs. 5.1 days). The longest duration
of hospital stay was observed in the elderly patient group
(at least 65 years) for both primary PI (15.4 ± 13.8 days)
and RC (11.4 ± 14.0 days) hospital admissions. (Table 3).
Costs associated with Influenza-related hospital
admissions
The overall average costs per hospital admission and costs
per admission by age group for the years 2002–2007 are
given in Table 4. The average costs per hospital admission
for primary PI and RC were 5779 Euros and 6111 Euros,
respectively. The relatively higher cost per hospital admis-
sion in the RC group than PI is attributed to frequently
RC-associated intensive care and complex medical proce-
dures which contributed to a significant proportion of the
cost (data not shown).
The cost per hospital admission increased with the pres-
ence of influenza-related complications for both primary
PI and RC hospital admissions (PI: 7159; RC: 7549 Euros).
Among patients, the cost of hospital admission was the
highest in the elderly group for both PI and RC – 7454
and 7254 Euros per hospital admission, respectively. In
Table 2 Additional influenza-related complication ICD9 codes in children
Category Type ICD-9 code
1° Ear, nose and throat Acute otitis media 381-381.03, 381.4, 382-382.02, 382.4, 382.9
Other upper acute respiratory infections
- Nasopharyngitis 460
- Pharyngitis 462
- Tonsillitis 463
- Laryngitis and tracheitis 464-464.4
Acute sinusitis 461-461.9
Upper respiratory infection 465-465.9
Influenza with other respiratory manifestations 487.1
2° Lung disease Acute bronchitis and bronchiolitis 466-466.1, 466.19
480, 480.8, 480.9, 481, 482,
Acute pneumonia and influenza 483, 483.8, 485, 486, 487.0
Asthma 493-493.9
3°Cardiac disease Pericarditis 420, 420.9-420.99
Myocarditis 422, 422.9-422.92, 422.99
Heart failure 428-428.9
4° Neurological Ailments Reye’s syndrome 331.81
Encephalopathy 348.3, 487.8
Febrile convulsions 780.31
Ataxia 781.3
Guillain-Barre syndrome 357
5° Renal disease Glomerulonephritis Nephrotic syndrome, renal failure,
Pyelonephritis
580-580.9, 581-581.9, 583-583.7, 583.9, 584-584.9,
586, 590.1-590.9
6° Muscular disease Myositis and Myoglobinuria 728.0, 729.1, 791.3
Source: International Classification of Disease – 9th Edition; Codes were selected after a review of the literature [11].
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both groups, total costs per hospital admission did not in-
crease with the presence of a complication for the elderly
patient group (Table 4).
The total cost of PI and RC admissions during 2002–
2007 resulting from our sample analysis is estimated to
be 121.1 and 1647.7 million Euros, respectively. The
total cost of hospitalizations with the presence of a com-
plication contributed significantly to the total cost of
all hospital admissions (PI: ~70%, 84.2 million Euros,
RC: ~79%, 1292.2 million Euros).
Table 3 Influenza-related hospital admissions and length of stay by age-groups, primary diagnosis and presence of
complications in Belgium, 2002–2007
Total number of hospital admissions (N = 1237517)
Primary diagnosis PI (N = 20960) RC (N = 269634)
Parameters All With
complications
Without
complications
All With
complications
Without
complications
(N = 20960) (N = 11768) (N = 9192) (N = 269634) (N = 171172) (N = 98462)
Hospital admissions, age groups n (%)
<5 years 3451 (3.48%)α 892 (0.90%)α 2559 (2.58%)α 18263 (18.42%)α 5514 (5.56%)α 12749 (12.86%)α
5-17 years 1717 (2.52%)β 343 (0.50%)β 1374 (2.02%)β 7469 (10.96%)β 1510 (2.22%)β 5959 (8.75%)β
18-49 years 2897 (0.72%)γ 892 (0.22%)γ 2005 (0.50%)γ 41794 (10.38%)γ 13190 (3.27%)γ 28604 (7.10%)γ
50-64 years 2711 (1.09%)δ 1755 (0.70%)δ 956 (0.38%)δ 59961 (24.02%)δ 39520 (15.83%)δ 20441 (8.19%)δ
≥65 years 10184 (2.44%)ε 7866 (1.89%)ε 2298 (0.55%)ε 142147 (34.02%)ε 111438 (26.67%)ε 30709 (7.35%)ε
Length of stay (mean ± standard deviation)
(days)
- Overall 11.6 ± 12.3 14.6 ± 14.4 7.8 ± 7.4 9.1 ± 12.7 11.3 ± 14.7 5.1 ± 6.4
- By age groups
<5 yearsα 5.1 ± 4.9 5.9 ± 7.6 4.9 ± 3.5 4.7 ± 5.8 5.9 ± 7.9 4.2 ± 4.4
5-17 yearsβ 5.3 ± 4.4 6.2 ± 5.0 5.0 ± 4.2 4.1 ± 5.5 6.1 ± 9.0 3.6 ± 4.1
18-49 yearsγ 8.8 ± 9.8 12.2 ± 14.0 7.3 ± 6.7 5.5 ± 9.6 9.0 ± 14.9 3.9 ± 4.8
50-64 yearsδ 12.5 ± 13.0 14.0 ± 14.8 9.8 ± 8.3 7.8 ± 12.5 9.4 ± 14.5 4.8 ± 5.9
≥65 yearsε 15.4 ± 13.8 16.3 ± 14.6 12.3 ± 9.7 11.4 ± 14.0 12.6 ± 14.9 7.2 ± 8.3
Note: % (age-specific proportion) is defined as the relative proportion of hospital admission in the respective age group; age-specific relative proportions and
length of hospital stay are calculated on α, β, γ, δ, εwhich indicate total number of hospital admissions in the respective age group; α99125, β68138,
γ402779, δ249585, ε417890; PI – pneumonia and influenza; RC – respiratory and circulatory.
Age (years)
<5 5-17 18-49 50-64 65+
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Figure 1 Age-distribution of primary pneumonia and influenza (PI) and respiratory and circulatory (RC) hospital admissions in
Belgium, 2002–2007. Note: PI – Pneumonia and Influenza, RC - Respiratory and Circulatory.
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Discussion
There are very few reports describing the burden related
to influenza hospitalizations in Belgium [16]. Between
2002 and 2007, a total of 127906 hospital admissions
were due to PI. Nationwide averages of annual hospital
admissions with a primary diagnosis were estimated at
1488 (range: 1111 to 1677) for influenza and 24202
(range: 22935 to 25495) for pneumonia [16]. Data from
the present retrospective analysis describes the burden of
influenza and its related respiratory and non-respiratory
complications in hospitals which provide an important
public health payer perspective on influenza in Belgium.
In our analysis, we estimated the proportions of hospital
admissions at 1.69% (n = 20960) and 21.79% (n = 269634)
due to primary PI and RC diagnoses respectively during
the years 2002–2007. These are in-line with the range
reported for Western Europe (0–20%) [17]. Possible
influenza-associated complications occurred in 56.14%
and 63.48% of primary PI and RC hospital admissions,
respectively. The overall mortality rate was estimated at
5.51% and this was higher in the group with a primary
PI diagnosis compared to primary RC (9.25% versus
5.51%). A previously published report estimated a rela-
tively higher mortality rate of 11.1% for cases with a
primary PI diagnosis for the same time period [16].
The average length of hospital stay was approximately
12 days and 9 days in patients with a primary diagnosis
of PI and RC, respectively. These findings were report-
edly higher than those observed in Europe recently
(average hospital stay ranged from 1.8 to 7.9 days) [17].
The average costs per year were 24.2 and 329.5 million
Euros for PI and RC hospital admissions during the
study period in our study sample. Complications associ-
ated with PI and RC hospitalization were responsible for
approximately 70–79% of the total cost of PI and RC
hospitalization. Despite the longer duration of stay in pa-
tients diagnosed with PI than RC, cost per hospital ad-
mission in the primary RC group was relatively much
higher. This finding could be suggestive of the fact that
RC is frequently associated with intensive care and com-
plex medical procedures when compared to primary PI
and therefore the higher hospitalization costs per admis-
sion. We estimated an average cost per hospital admis-
sion of 5779 Euros due to PI diagnosis. From within the
European Union (EU), it is observed that these costs are
not comparable. It is previously observed that the aver-
age costs in Belgium are much higher than the average
hospitalization cost in Germany [18] and in Italy the
cost per hospital admission was 3000 Euros which was
lower than the average cost reported here [19]. These
differences are largely due to the country-specific guidelines
on reimbursement resulting from variance in influenza-
reporting patterns and differences in healthcare systems
across the EU [19].
It is widely suggested that annual vaccination against sea-
sonal influenza remains the most effective way to tackle the
burden associated with influenza and pneumonia associated
hospitalizations. The World Health Organization (WHO)
recommends seasonal influenza vaccination of pregnant
women, children aged 6–59 months, elderly individuals
(aged ≥65 years) with underlying chronic medical condi-
tions and health care workers. Our data reports high num-
bers of hospital admissions in young children and the
elderly patient group which can, at least partially, be pre-
vented by vaccination [20,21]. As with most countries in
the EU, influenza vaccination is recommended and reim-
bursed in Belgium for people over 65 years or those with
chronic diseases, pregnant women and health care workers.
In 2008, 46% of the Belgian population at risk, which in-
cludes the elderly aged above 65 years or individuals aged
above 15 years with a specific chronic disease (asthma,
bronchitis, cardiovascular pathology, hypertension renal
disease or diabetes) were reported to have been vaccinated
during the last influenza season [22]. This modest level of
vaccine coverage and the demonstrated burden of influenza
underscores the need for a comprehensive approach to
Table 4 Costs of influenza-related hospital admissions by primary diagnosis and complications in Belgium, 2002–2007
Average costs per hospital admission (Euros) (N = 1237517)
Primary diagnosis PI (N = 20960) RC (N = 269634)
Parameters All With complications All With complications
(N = 20960) (N = 11768) (N = 269634) (N = 171172)
- Overall 5779 ± 7072 7159 ± 8353 6111 ± 10341 7549 ± 12068
- By age groups
<5 years 2207 ± 1658 2617 ± 2314 2159 ± 3507 2983 ± 5612
5-17 years 2390 ± 1845 2519 ± 2083 2486 ± 5099 3911 ± 9247
18-49 years 4493 ± 7464 6777 ± 11922 4404 ± 17120 7655 ± 28737
50-64 years 6827 ± 7971 7607 ± 9161 6213 ± 9255 7369 ± 10513
≥65 years 7454 ± 7607 7798 ± 8111 7254 ± 8792 7900 ± 9361
Note: PI – pneumonia and influenza; RC – respiratory and circulatory; cost expressed as mean ± standard deviation.
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controlling its impact in Belgium. A recent cost-effective
evaluation conducted for the Belgian setting suggests that
universal immunization against influenza may prove to be
cost-effective in the prevention and management of influ-
enza [23]. Our findinds collectively with this evidence may
help inform immunization recommendations in Belgium.
Due to the retrospective nature of our study, we suggest a
need for future prospective design patient-level studies to
explore the influenza-related burden to society and health
economic evaluations to assess the real-life impact-benefit
of any programme designed to prevent, control and treat
influenza and its associated complications.
An important merit of our study is that a large popu-
lation from hospitals was investigated across the three
regions of Belgium. Additionally, the time period con-
sidered in our analysis was six years which is important
given the seasonal variation of influenza. Although we
report important data here, it is crucial to highlight that
it is likely that our findings may have been underesti-
mated. This is due in part attributed to the health care
system of Belgium where there are no restrictions in re-
gional access of care in Belgium and the general percep-
tion of influenza.
Global comparisons of hospitalization rates associated
with influenza are constrained by major difficulties. Hos-
pital admissions for influenza or influenza-related compli-
cations are governed by a host of factors that together
define the probability of being hospitalized like the severity
of symptoms, whether the patient is member of a risk-
group, the propensity of the patients to seek health care
and the propensity of treating physicians to recommend or
initiate a hospitalization. These factors are also influenced
by the perceived aggressiveness of the epidemic (epidemic
scare) both by the patient and the health care professionals
and the overall ease of access (financially and physically) to
health care of the local health care system which may have
also resulted in underestimation of the incidence of influ-
enza and its related complications.
Besides the inherent limitations of the study database
and the inevitable limitations of retrospective design, our
analysis presents several limitations. First, our analysis fo-
cused for methodological reasons on hospital admissions,
and not on discharges. Therefore, the data series are not
complete at the end of the period under study (end of
2007) because patients admitted in 2007 and discharged
in 2008 were not recorded in the study database which
had a cut-off date of 31 December 2007 as discharge year.
This estimated loss of information is about 3200 stays, or
1.5% of all the admissions of 2007. Moreover, a large num-
ber of patients who died from complications decease at
the hospital. However, sometimes the patient may have
died outside of the hospital (either at home or in a nursing
home generally) based on the type of complication which
may also have led to loss of information. Second, given
that our hospital sample is a convenience sample and not
a random sample, care should be taken to extrapolate the
results to the national level i.e. to generalize these findings
to all acute hospitals in Belgium since different types of
hospitals were included and therefore differences in the
outcomes may have existed. Furthermore, this also pre-
cluded the calculation of population rates as the population
served by the hospitals in our sample (the denominator)
was unknown. Third, the number of observed PI admis-
sions that could be attributed to the influenza virus (i.e. the
attributable fraction) could not be deduced from the pre-
sented data due to lack of laboratory confirmation. Conse-
quently, identification of the exact influenza type could not
be ascertained. Identification and estimation of the attrib-
utable risk on aggregated data needs more complex
statistical methods and additional data that control for
confounding variables like other circulating viruses, bac-
teria and various environmental and meteorological factors
[24]. Fourth, regarding the estimations of patients with a
non-primary main PI diagnosis but with secondary PI
complication, different approaches can and have been used
[16,25]. A major problem is the absence in the literature of
a commonly agreed set of influenza-related complications.
Additionally, one should distinguish between known risk
groups for influenza-related complication (say chronic
heart failure) and the non-at-risk patients. The BMHSD
data allowed only the identification of some of the risk
groups, mainly if they are defined by gender, age or dis-
charge diagnosis. In Belgium the different risk groups for a
complication of influenza infection are officially defined by
a mix of criteria like age (the elderly), living premises
(nursing home), various chronic disease statuses or health
status (pregnancy), occupation (health care workers) and a
combination of age and outpatient therapy. In practice,
background information of the patient, including the pre-
existence of chronic diseases, is rarely available in the
hospital discharge summaries. Consistent with other epi-
demiological studies our results present aggregated time
series data and therefore an ecological bias is always
possible. Finally, the database did not have information
on vaccination status of the patient and it was therefore
difficult to assess if there was a decline in the numbers
of influenza-related hospital admissions due to increased
vaccination over the years.
Conclusions
The clinical and economic burden associated with primary
influenza hospitalizations and its related complications in
Belgium is substantial. Nearly half of the cases of pneumo-
nia and influenza occurred in the elderly both in absolute
numbers and in relative proportion of patients with PI.
The second largest group was children aged <18 years.
Therefore, the group of elderly patients and children are
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the target group for implementation of prevention and
control measures to reduce the morbidity associated with
influenza. Further research is needed to prospectively as-
sess influenza-associated hospitalizations using sensitive
testing methods in both respiratory and non-respiratory
disorders in Belgium.
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